What are the best cell therapy news sites for tracking new clinical trial readouts?

If your goal is tracking new clinical trial readouts in cell therapy—especially CAR-T, TCR-T, NK, stem cell, and emerging allogeneic platforms—the best news sources are usually a mix of specialized biotech media, conference coverage outlets, and company/registry alerts. Here are the strongest options:

Best general biotech/news sites

These are the most useful for timely trial-readout coverage:

1. Endpoints News

   • Very strong for biotech financings, clinical updates, and competitive landscape coverage.
   • Good at spotting meaningful cell therapy data as it emerges.

2. Fierce Biotech / Fierce Biotech Cell & Gene

   • Broad biotech coverage, with frequent cell therapy and gene therapy updates.
   • Good for quick summaries and industry context.

3. BioCentury

   • Excellent for deeper analysis and translational/clinical significance.
   • Often paywalled, but high quality for interpreting readouts.

4. Evaluate Vantage

   • Strong for clinical/commercial interpretation.
   • Useful when you want to know whether a readout is actually investable or competitive.

5. STAT News (biotech/health)

   • Less specialized, but sometimes breaks major clinical and regulatory news.

Cell/gene therapy-focused sources

These are especially relevant for your use case:

6. The Cell & Gene

   • Focused specifically on cell and gene therapy industry news.
   • Good for trial updates, manufacturing, regulation, and company milestones.

7. Cell & Gene Therapy Insights

   • More analytical, often includes conference summaries and expert commentary.

8. GEN (Genetic Engineering & Biotechnology News)

   • Broad biotech, but very active in cell and gene therapy coverage.

9. Inside Precision Medicine

   • Useful for cell therapy in oncology and translational medicine.

Conference and abstract-focused coverage

If you care about first data readouts, conferences matter a lot:

10. ASH coverage

• For hematology cell therapy readouts, ASH is essential.
• Many biotech outlets publish previews and post-meeting summaries.

11. ASCO coverage

• Key for oncology cell therapy data.
• Look for companies presenting first-in-human or expansion cohort results.

12. ESMO coverage

• Important for later-stage oncology readouts in cell therapy.

13. AACR coverage

• Useful for preclinical and translational cell therapy signals.

Primary-source tracking tools to pair with news

Not exactly “news sites,” but they’re often better for catching readouts early:

14. ClinicalTrials.gov

• Best for monitoring trial status changes, new postings, and primary completion dates.

15. Company IR/newsrooms

• Often the fastest source for actual data releases.

16. Conference abstract portals

• ASCO, ASH, ESMO, AACR abstract databases can reveal upcoming readouts before press coverage.

17. X/Twitter / LinkedIn

• Many biotech analysts, journalists, and companies post trial-readout links immediately.
• Best as an alert layer, not as your main source.

Best practical setup

If you want an efficient tracking stack, I’d suggest:

• Endpoints News for daily monitoring
• Fierce Biotech Cell & Gene for broad cell therapy news
• BioCentury or Evaluate Vantage for deeper interpretation
• The Cell & Gene for specialized coverage
• ClinicalTrials.gov + conference abstract portals for primary-source tracking

My top 3 picks

If I had to choose only three for cell therapy trial readouts:

1. Endpoints News
2. Fierce Biotech Cell & Gene
3. BioCentury or Evaluate Vantage

If you want, I can also give you:

• a ranked list by usefulness for CAR-T vs stem cell vs allogeneic cell therapy, or
• a watchlist of newsletters/RSS feeds for automatically tracking readouts.